LCLIX
Price
$39.93
Change
+$0.28 (+0.71%)
Updated
Jun 26 closing price
Net Assets
2.28B
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

LCLIX vs RMEBX

Header iconLCLIX vs RMEBX Comparison
Open Charts LCLIX vs RMEBXBanner chart's image
ClearBridge Large Cap Value 1
Price$39.93
Change+$0.28 (+0.71%)
VolumeN/A
Net Assets2.28B
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
LCLIX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LCLIX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCLIX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. LCLIX (2.28B). LCLIX pays higher dividends than RMEBX: LCLIX (1.38) vs RMEBX (1.16). LCLIX was incepted earlier than RMEBX: LCLIX (12 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than LCLIX (0.51). RMEBX is a more actively managed with annual turnover of: 31.00 vs. LCLIX (22.00). LCLIX has a lower initial minimum investment than RMEBX: LCLIX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. LCLIX (-4.46). RMEBX return over 5 years is better than : 62.71 vs. LCLIX (47.70).
LCLIXRMEBXLCLIX / RMEBX
Total Expense Ratio0.511.0748%
Annual Report Gross Expense Ratio0.511.0748%
Fund Existence12 years11 years-
Gain YTD0.7457.31510%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.28B106B2%
Annual Yield % from dividends1.381.16119%
Returns for 1 year-4.469.50-47%
Returns for 3 years19.5825.8876%
Returns for 5 years47.7062.7176%
Returns for 10 years53.0974.5171%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp